Context: Electronegative low-density lipoprotein (LDL) L5 is a naturally occurring, atherogenic entity found at elevated levels in the plasma of patients with metabolic syndrome (MetS) in the absence of elevated plasma LDL levels.
Conclusions: L5 induces adipose inflammation through LOX-1 by promoting macrophage maturation and infiltration into adipose tissue. Elevated plasma L5 levels may be a novel etiology of adipose tissue inflammation in patients with MetS. (J Clin Endocrinol Metab 102: [4615] [4616] [4617] [4618] [4619] [4620] [4621] [4622] [4623] [4624] [4625] 2017) T he lowering of plasma low-density lipoprotein (LDL) levels remains the primary target of atherosclerosis treatment (1) . Paradoxically, an elevated LDL level is not a criterion for metabolic syndrome (MetS) (2) , which is strongly associated with the development of atherosclerosis (1) . Factors that contribute to metabolic abnormalities include dysglycemia, high blood pressure, elevated triglyceride levels, low high-density lipoprotein levels, and central obesity (2) . The prevalence of central obesity is globally increasing, especially in developed countries (3) . The link between obesity and MetS has been extensively studied, and results have shown that the inflammation-associated dysfunction of adipocytes plays a role in the development of insulin resistance and diabetes, which are risk factors for MetS (4) . Adipose tissue, now classified as an endocrine tissue, produces and secretes bioactive substances known as adipocytokines or adipokines, such as adiponectin, leptin, monocyte chemoattractant protein 1 (MCP-1), and tumor necrosis factor a (TNF-a), which play important roles in lipid homeostasis and cell signaling (5) . Central obesity induces the hypertrophy of adipocytes, resulting in the increased production of proinflammatory cytokines by cells of the innate immune system, such as macrophages (6, 7) . In addition, adipocytokine malfunction interferes with insulin signaling (8) . Thus, the uncontrolled production and/or secretion of adipocytokines by dysfunctional adipocytes leads to the inception of central obesity-linked complications (9) .
Several studies have proposed various mechanisms and factors that may lead to adipocyte inflammation associated with central obesity (6, 10) . Particularly, T cells are present in visceral adipose tissue before the manifestation of adipose tissue macrophages and play an important role in the initiation of inflammation, including macrophage activation and adipocyte differentiation (11, 12) . Vitamin D has been shown to inhibit macrophage infiltration in adipose tissue and reduce obesity-associated low-grade inflammation (13) .
The lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) is required for the expression of proinflammatory cytokines in the adipose tissue of obese mice fed with a high-fat diet (14) . Therefore, lipoproteins may play an important role in adipose tissue inflammation. Interestingly, LOX-1 is expressed in macrophages (15) . Several studies have implicated macrophages as producers of proinflammatory cytokines in the process of adipose tissue inflammation (16) .
Electronegative L5 LDL, isolated by subfractionating human LDL by using fast-protein liquid chromatography (FPLC) with an anion-exchange column, is atherogenic in vivo and in vitro (17) . L5 induces endothelial cell dysfunction and apoptosis through the LOX-1 receptor by suppressing phosphoinositide 3 kinase/Akt signaling and fibroblast growth factor 2 autoregulation (18, 19) . In addition, L5 enhances endothelial cell activation and platelet aggregation, thereby promoting thrombosis that leads to ST-segment elevation myocardial infarction or stroke (20, 21) . In clinical studies, increased L5% (i.e., percentage of L5 in total LDL) and [L5] (i.e., plasma concentration of L5) have been strongly associated with cardiovascular diseases (17) . Thus, L5% is a valuable parameter that can be monitored to determine the efficacy of statin therapy and other treatments (22) . In this study, we hypothesized that L5 LDL plays an important role in adipose tissue inflammation by promoting the activation and infiltration of macrophages in adipose tissue through LOX-1 signaling. Using L5 isolated from patients with MetS, we studied the direct effects of L5 on mouse adipose tissue, as well as the indirect effects of L5 on human monocytes and macrophages.
Materials and Methods

Study design and clinical diagnosis
This study was approved by the institutional review board of Kaohsiung Medical University Hospital in Taiwan. Between October 2010 and August 2014, 58 participants were enrolled in our study and gave written informed consent in accordance with the Declaration of Helsinki. Patients were diagnosed with MetS if three or more MetS criteria were met. According to the medical history and clinical profile of each participant, we assigned them to either a cohort of asymptomatic patients with three or more MetS criteria (MetS group, n = 29) or a control cohort of patients with two or fewer MetS criteria (non-MetS control group, n = 29). Lipid parameters for all study participants were measured at Kaohsiung Medical University Hospital by using standard operating procedures.
LDL isolation and L5 analysis
Whole-blood samples (20 mL) were freshly collected and anticoagulated with 5 mM EDTA. To prevent contamination and protein degradation, 1% penicillin/streptomycin and Complete Protease Inhibitor Cocktail (Roche Diagnostics, Indianapolis, IN) were added into plasma samples. LDL (density = 1.019 to 1.063) was then isolated by using sequential potassium bromide density ultracentrifugation with a Beckman Optima L-100K ultracentrifuge (Beckman Coulter, Indianapolis, IN) equipped with a Type 90 Ti fixed angle rotor. After LDL samples were dialyzed with 0.02 M Tris buffer (with 0.5 mM EDTA, pH 8.0) three times for 24 hours each, samples were injected into anÄKTA FPLC system (GE Healthcare Life Sciences, Pittsburgh, PA) equipped with an Uno-Q12 anionexchange column (Bio-Rad Laboratories, Berkeley, CA). According to the sequential changes in NaCl concentration, LDL was further divided into five subfractions, L1 to L5, as previously described (19) . The effluent was monitored at 280 nm. LDL subfractions were concentrated by using Centriprep centrifugal filters (YM-30; Merck Millipore, Danvers, MA) and sterilized by passing through 0.22-mm filters (Merck Millipore). The isolated subfractions were N 2 -sealed and stored at 4°C until sample characterization (19) . The Pierce Bicinchoninic Acid (BCA) Protein Assay Kit (Thermo Fisher Scientific, Cambridge, MA) was used according to the manufacturer's instructions to estimate the concentration of L1 or L5.
Cell culture of adipocytes
Human white preadipocytes (PromoCell GmbH, Heidelberg, Germany) were cultured in 6-well culture plates and differentiated for 3 days in an incubator set at 37°C with 5% CO 2 (Thermo Fisher Scientific, Waltham, MA). After differentiation, adipocytes were maintained in nutrition media for 2 weeks as per the instruction manual guidelines. Cells were then treated with phosphate-buffered saline (PBS; control), 100 mg/mL L1, 25 mg/mL L5, or 50 mg/mL L5 with or without pretreatment with the LOX-1 neutralizing antibody TS-92 (20 mg/mL). From each culture, conditioned culture media (CCM) were collected. Vivaspin sample concentrators 30K MWCO (GE Healthcare Life Sciences) were used to remove LDL from the CCM. LDL-free CCM was then examined for cytokine expression and its effects on THP-1 cells.
Cell culture of monocytes THP-1 monocytic cells (American Type Culture Collection, Manassas, VA) were maintained in RPMI 1640 (Thermo Fisher Scientific) containing 2 mM L-glutamine, 0.1 mg/mL streptomycin, 100 IU/mL penicillin, and 50 mM 2-mercaptoethanol supplemented with 10% heated-inactivated fetal bovine serum (Gibco, Thermo Fisher Scientific). THP-1 cells (7 3 10 5 ) were seeded into 24-well Millicell cell culture inserts (Merck Millipore), and LDL-free CCM was added to the lower migration plate. Cells were cultured at 37°C with 5% CO 2 for 24 hours. Migrated cells were observed by using a light microscope (Nikon Instruments, Melville, NY) and were analyzed with immunostaining and a FACScalibur flow cytometer (BD Biosciences, San Jose, CA).
Flow cytometry
THP-1 cells were cocultured in 24-well Millicell cell culture inserts (Merck Millipore) with LDL-free CCM from adipocytes treated with PBS, L1, or L5 for 24 hours. Migrated cells were stained with antibodies against the mature macrophage cell marker PM-2K (Abcam, Cambridge, MA). Fluorochromelabeled monocytes were analyzed with a FACScalibur flow cytometer (BD Biosciences, San Jose, CA). For each treatment group, 50,000 cells were analyzed for the expression of PM-2K.
Cytokine array
Human Cytokine Array Panel A (Proteome Profiler Arrays; R&D Systems, Minneapolis, MN) was used per the manufacturer's instructions. Samples were diluted and mixed with a cocktail of biotinylated detection antibodies. After the sample/ antibody mixture was incubated with Human Cytokine Array Panel A, washing was performed to remove unbound materials. Streptavidin-horseradish peroxidase and chemiluminescence detection reagents were sequentially added. Signals were visualized and recorded with a UVP BioSpectrum 600 image analyzer (UVP Life Science, Cambridge, UK).
Western blotting
Adipocytes were lysed in a radioimmunoprecipitation assay buffer (Sigma-Aldrich, St. Louis, MO). Samples were separated with sodium dodecyl sulfate polyacrylamide gel electrophoresis (4% to 20% gels; Thermo Fisher Scientific) and transferred to a polyvinylidene difluoride membrane (Merck Millipore). Membranes were probed with primary antibodies against TNF-a, adiponectin, visfatin (GeneTex, Irvine, CA), peroxisome proliferator-activated receptor g (PPAR-g; Cell Signaling Technology, Danvers, MA), and b-actin (Sigma-Aldrich). Signals were visualized and recorded with a UVP BioSpectrum 600 image analyzer (UVP Life Science).
Animals
L5 or L1 (5 mg/kg each) from patients with MetS or PBS (negative control) was injected into the tail vein of 8-week-old C57BL/6 (wild-type) male mice (BioLASCO Taiwan, Taipei, Taiwan) or LOX-1 knockout mice (LOX-1 2/2 ; provided by Dr. T. Sawamura) twice a week for 6 weeks (n = 5 for each treatment group). Eight-week-old male Golden Syrian hamsters were fed with a normal chow diet (ND; Test Diet, Richmond, IN) or a high-fat diet (i.e., chow diet supplemented with 11.5% coconut oil, 11.5% corn oil, and 1% cholesterol) (n = 4 per group) for 12 weeks, as previously described (23, 24) . At the end of these experiments, mice or hamsters were euthanized, and adipose tissue and serum samples were collected for further analysis. All animal protocols were compliant with the Institutional Animal Care and Use Committee of Kaohsiung Medical University.
Immunohistochemistry
Adipose tissue sections from wild-type mice injected with PBS, L1, or L5 and from LOX-1 2/2 mice injected with L5 or PBS were deparaffinized and rehydrated. For immunostaining, sections were washed in PBS and incubated with 1% bovine serum albumin for 30 minutes to block nonspecific staining. Sections were drained and incubated for 3 hours at room temperature in a humidity chamber with each respective antibody for immunohistochemical analysis, including anti-F4/ 80 (Thermo Fisher Scientific) and anti-CD11c antibodies (Abgent, San Diego, CA) diluted with antibody diluent (Agilent Technologies, Sugar Land, TX). After sections were washed in PBS, endogenous peroxidase activity was blocked by incubating sections in 0.3% H 2 O 2 in methanol for 20 minutes, followed by sequential 10-minute incubations with biotinylated antibody and peroxidase-labeled streptavidin. Staining was complete after incubation with 3,3 0 -diaminobenzidine substrate-chromogen solution (Agilent Technologies) and counterstaining with hematoxylin. Images from similar regions of each section were captured by using bright-field microscopy (magnification, 3400; Nikon, Tokyo, Japan). Data were quantified by using ImageJ software (National Institutes of Health, Bethesda, MD).
Statistical analysis
All data are presented as the relative frequency for discrete responses and as the mean 6 standard deviation for continuous responses. A Student t test and x 2 test were used to compare the differences between control and MetS groups. Linear regression analysis with a 95% confidence band was used to examine the correlation of L5% (i.e., the percentage of L5 in total LDL) and [L5] (i.e., the concentration of L5 in mg/dL) with the number of MetS criteria met. A P value ,0.05 was considered statistically significant. The Statistical Package for Social Science (version 19.0; SPSS, Chicago, IL) was used to perform all statistical analyses.
Results
Clinical characteristics and biochemical profiles of study groups
The clinical characteristics and biochemical profiles of the MetS (n = 29) and non-MetS control groups are shown in Table 1 . Between the two groups, no significant difference was observed in sex, age, or smoking status (P = 0.39, P = 0.54, and P = 0.56, respectively). However, compared with the control group, the MetS group had a significantly higher mean waist circumference, systolic blood pressure, fasting blood sugar level, hemoglobin A1c level, and triglyceride level (P , 0.001, P = 0.05, P , 0.001, and P , 0.01, respectively; Table 1 ). In addition, the MetS group had a significantly lower high-density lipoprotein cholesterol (HDL-C) level than the control group (P , 0.01), but no significant difference was observed in body mass index, diastolic blood pressure, total cholesterol, or LDL cholesterol (LDL-C) level (P = 0.07, P = 0.06, P = 0.12, and P = 0.91, respectively; Table 1 ). Because the normal range of waist circumference values was different between men and women, we stratified the waist circumference data within each group according to sex. For the MetS group, the average waist circumference was 94.7 6 9.0 cm in men and 88.2 6 16.1 cm in women. For the control group, the average waist circumference was 86.7 6 6.1 cm in men and 75.1 6 8.4 cm in women. Because MetS was diagnosed in patients by using five criteria involving central obesity, blood pressure, and levels of HDL-C, glucose, and triglyceride, no further adjustments were made. The MetS group met 3.6 6 0.7 of the five MetS criteria, whereas the control group met 1.3 6 0.9 of the MetS criteria.
Elevation of plasma L5 level in the MetS group
LDL-C levels were similar between the MetS and control groups (P = 0.91). LDL from patients with MetS and controls was distinctly separated according to electronegativity into five subfractions (L1 to L5) by using FPLC with an anion-exchange column. The results of the FPLC analysis (Fig. 1A and 1B) showed that the LDL of patients with MetS contained a higher L5% than control LDL (5.3% 6 4.9% vs 2.1% 6 1.4%; P , 0.001; Fig. 1C ). The [L5], which was calculated as L5% 3 LDL-C (mg/dL), was also significantly higher in patients with MetS than in controls (7.3 6 9.8 mg/dL vs 3.0 6 2.0 mg/dL, P , 0.01).
Association of human plasma L5 levels with biochemical parameters and number of MetS criteria met
We examined the association between plasma L5 levels with various biochemical parameters. Interestingly, L5% was not correlated with LDL-C level. Because [L5] was derived from L5% 3 LDL-C (mg/dL), L5% was positively correlated with [L5] (P , 0.001). L5% was also positively correlated with waist circumference (R = 0.340, P = 0.01), fasting plasma glucose level (R = 0.56, P , 0.001), and hemoglobin A1c level (R = 0.39, P , 0.01), but it was not correlated with triglyceride level, systolic blood pressure, diastolic blood pressure, or HDL-C level (P = 0.53, P = 0.51, P = 0.10, and P = 0.63, respectively).
We also performed linear regression analysis with a 95% confidence band to examine the correlation of L5% and [L5] with the number of MetS criteria met. The Pearson correlation coefficient (R) was 0.33 for L5% (P , 0.05; Fig. 1D ) and 0.30 for [L5] (P , 0.05; Fig. 1E ), supporting a trend of increasing plasma L5 levels in study individuals with an increasing number of MetS criteria met.
Adipose tissue inflammation in L5-injected mice
To examine the effects of L5 on adipose tissue, we injected human L5 or L1 (5 mg/kg twice a week for 6 weeks) or PBS into the tail vein of wild-type C57BL/6 mice and LOX-1 knockout mice (n = 5 per group). In wild-type mice, the tail-vein injection of human L5 induced the accumulation of F4/80 + and CD11c + M1 macrophages in adipose tissue (25, 26) , whereas the injection of human L1 or PBS did not (Fig. 2) . The infiltration of macrophages in the adipose tissue of L5-injected mice appeared in crown-like structures. In LOX-1 knockout mice, the L5-induced accumulation of F4/80 + and CD11c + M1 macrophages in adipose tissue was partially attenuated (Fig. 2) .
Lipid droplet formation in cultivated adipocytes treated with L5
To examine the effects of elevated plasma [L5] on adipocytes, we treated well-differentiated adipocytes with 25 or 50 mg/mL human L5, followed by culture with nutrition media. Adipocytes were separately treated with PBS or 100 mg/mL L1 (negative controls) or 50 mg/mL oxidized LDL (positive control), which has physiologic effects similar to those of L5. Our preliminary results showed that 25 mg/mL L5 enhanced lipid droplet formation compared with L1 and PBS (data not shown), confirming that L5 enhances lipid droplet formation. Notably, 50 mg/mL L5 also induced cell death in adipocytes (data not shown).
The release of inflammatory adipocytokines from adipocytes induced by L5 LDL
Using Human Cytokine Array Panel A, we found that the treatment of human white adipocytes with L5 induced the release of inflammatory adipocytokines into the CCM, including complement (C5/C5a), GROa (CXCL1), IL-6, IL-8 (CXCL8), IP-10 (CXCL10), MCP-1, MIF, and RANTES (CCL5) (n = 5; Fig. 3A and 3B ), whereas treatment with L1 or PBS did not (n = 3 per group; Fig. 3A) . Furthermore, the pretreatment of cells with LOX-1 neutralizing antibody TS-92 significantly attenuated the L5-induced release of C5/C5a, GROa, IL-6, IL-8, IP-10, and RANTES (P , 0.05, n = 5; Fig. 3A and 3B) but did not significantly affect the L5-induced release of MCP-1 or MIF (P = 0.12 and P = 0.27, respectively, n = 5; Fig. 3B ). Therefore, our results indicate that the effect of L5 on the release of adipocytokines from adipocytes is partially mediated by LOX-1.
Monocyte migration in L5-treated adipocytes
To examine the cell-based mechanism for the effects of elevated plasma [L5] on adipocytes, we treated human white adipocytes with PBS, 100 mg/mL L1, or 25 or 50 mg/mL L5 after pretreatment with or without 20 mg/ mL TS-92 antibody. Twenty-four hours later, CCM was collected, and LDL was removed. The effects of LDL-free CCM on THP-1 cells were then studied by using a filter chamber-based cultivation system. Monocyte migration, marked by the number of monocytes that passed through a transwell system, was increased by 300-fold after the addition of LDL-free CCM from L5-treated adipocytes (n = 7, P , 0.001 vs CCM from L1-treated adipocytes; Fig. 3C ). Furthermore, adhesion, marked by the number of cells that adhered to the surface of the lower chamber, was increased by fivefold (n = 4, P , 0.01; Fig. 3D ). The CCM from L1-treated adipocytes did not significantly affect monocyte migration or adhesion. These findings suggest that L5 indirectly increases monocyte migration and adhesion. Migrated monocytes were collected and stained with PM-2K monoclonal antibody specific for the matured macrophage cell surface marker. The LDL-free CCM of L5-treated adipocytes induced THP-1 cell differentiation to PM-2K + macrophages (n = 3; Fig. 3E ).
Adipocyte inflammation induced by L5 LDL
Western blot analysis of adipocytes lysed in radioimmunoprecipitation assay buffer showed that L5 increased the expression of TNF-a (P , 0.01, n = 7; Fig. 4A ) and visfatin (P , 0.01, n = 7; Fig. 4B ) in a dosedependent manner but decreased PPAR-g (P , 0.01, n = 7; Fig. 4C ) and adiponectin (P , 0.05, n = 4; Fig. 4D ) expression. Pretreatment of adipocytes with LOX-1 neutralizing antibody TS-92 attenuated TNF-a expression induced by L5 and enhanced adiponectin expression (P , 0.05; n = 7 and n = 4, respectively; Fig. 4A and 4D) , suggesting that L5 alters adipocyte protein expression through a LOX-1-dependent pathway.
Adipose tissue inflammation in a hamster model of endogenously elevated L5 LDL levels Previously, we have shown that Golden Syrian hamsters fed with a high-fat diet have significantly higher plasma levels of L5 LDL than do hamsters fed with an ND (23, 24) . Furthermore, the plasma concentration of L5 in Golden Syrian hamsters fed with a high-fat diet is similar to the concentration of L5 in patients with MetS (24) . We found that F4/80 + and CD11c + M1 macrophages accumulated in the adipose tissue of Golden Syrian hamsters fed with a high-fat diet but not in those fed with an ND (Fig. 5A and 5B). Western blot analysis of adipose tissue from Golden Syrian hamsters fed with a high-fat diet showed the increased expression of interferon g (Fig. 5C ), TNF-a (Fig. 5D ), IL-6 (Fig. 5E ), and visfatin ( Fig. 5F ) but decreased expression of adiponectin (Fig. 5G) .
Discussion
Several studies have established the atherogenicity of L5, implicating this highly electronegative LDL as a main factor in the onset of cardiovascular diseases (17, 20) . Importantly, L5 has also been implicated in obesityrelated disorders such as MetS (17) . In this study, we showed that L5 induces the release of inflammatory adipocytokines from adipocytes and leads to the activation, migration, and differentiation of macrophages. In the adipose tissue of mice injected with human L5 twice a week for 6 weeks, we observed the accumulation of F4/ 80 + and CD11c + M1 macrophages (25) . Moreover, we confirmed the presence of adipocyte inflammation in a previously established Golden Syrian hamster model of endogenously elevated L5 LDL (23) . Thus, our findings suggest that electronegative L5 LDL has a role in the etiology of adipose tissue inflammation associated with MetS. Plasma L5 concentrations have been shown to be significantly higher in patients with MetS than in controls (27) . Consistent with previous findings, we showed that LDL from the MetS group contained a higher percentage of L5 than did the LDL of the control group (5.3% 6 4.9% vs 2.1% 6 1.4%, respectively; P , 0.001), despite similar LDL-C levels between these groups. This suggests that the increased plasma L5 concentration in patients with MetS may be associated with the dysfunction, inflammation, and hypertrophy of adipocytes that occur in MetS and obesity.
In patients with MetS, chronic inflammatory conditions are present (28) . These inflammatory conditions have been associated with the onset of MetS, as well as its pathophysiologic consequences (29) . L5 has been shown to enhance the production of proinflammatory cytokines, which activate macrophages and lead to chronic inflammation (15, 16) . LOX-1, the receptor for L5, which is expressed on macrophages and adipocytes (14, 15) , internalizes L5, resulting in macrophage activation (30) . Our findings showed that the effects of L5 on macrophage infiltration and migration were attenuated in the absence of LOX-1 or in the presence of LOX-1 neutralizing antibody, indicating that LOX-1 is required for L5's effects on adipose tissue inflammation.
Using in vitro and in vivo experimental models, we characterized the crosstalk underlying the mechanism of F4/80 + and CD11c + M1 macrophage infiltration in adipose tissue. In white human adipocytes, L5 induced the release of inflammatory adipocytokines, including MCP-1, RANTES, GROa, and C5/C5a, which may enhance the migration and infiltration of CD8 + T cells into adipose tissue (12) . Adipocytokines have been shown to have an important role in inflammation, insulin resistance, and obesity, which is closely associated with metabolic complications (31) . L5 also induced the release of interferon g, TNFa, IL-6, IP-10, and MCP-1 in human adipocytes, which may in turn activate the transformation of monocytes to M1 macrophages (32) . The aggregation of M1 macrophages in adipose tissue has been shown to further worsen adipocytic dysfunction (33) . In this study, we also found that L5 induced the expression of visfatin in adipocytes. Visfatin plays an important role in inflammation and insulin sensitivity (34) . Increased serum concentrations of visfatin have been positively correlated to ischemic stroke, type 2 diabetes, obesity, and nonalcoholic fatty liver disease (35, 36) . In addition, we found that L5 decreased the expression of PPAR-g and adiponectin. PPAR-g is a key regulator for adipocyte differentiation (37) . Downregulation of PPARg by L5 may worsen inflammatory responses and correlate with insulin resistance. Adiponectin, on the other hand, is involved in lipid metabolism and has antidiabetic, antiatherogenic, and anti-inflammatory activities (38) . The downregulation of PPAR-g and adiponectin by L5 may further impair adipocytokine functions (39) .
In mice that received the tail-vein injection of L5 twice daily for 6 weeks, inflammatory macrophages accumulated in adipose tissue and formed a crown-like structure, + and CD11c + M1 macrophages accumulated in the adipose tissue of Golden Syrian hamsters fed with a high-fat diet (HFD), previously shown to have elevated levels of L5 LDL, but not in that of hamsters fed with an ND (n = 4 hamsters per group). Western blot analysis of adipose tissue from both groups of mice showed increased expression of (C) interferon g (IFNg), (D) TNF-a, (E) IL-6, and (F) visfatin but decreased expression of (G) adiponectin. *P , 0.05. Scale bar = 50 mm.
which may induce adipocyte apoptosis and fibrosis (33, 40) . To rule out the possibility of xenoantigen-induced inflammation, we used Golden Syrian hamsters fed with a high-fat diet as an animal model for studying the effects of endogenously increased L5 LDL levels. Our results confirmed the association between highly electronegative L5 LDL and the infiltration of F4/80 + and CD11c + M1 macrophages in adipose tissue.
In conclusion, L5 induces the release of inflammatory cytokines from adipocytes, resulting in the transformation of monocytes to matured macrophages. The aggregation of these macrophages in adipose tissue further worsens adipocytic dysfunction. Given that L5 is correlated to waist circumference in obese individuals and is the only LDL subfraction that can signal through LOX-1, our evidence is consistent with a pathogenic role of L5 in MetS.
